Abstract:In the ever-evolving landscape of biomedical research, 3D Cell Culture (3DCC) systems have become essential for replicating in vivo environments and promoting more physiologically cellular interactions and microenvironment. 3DCC models can be beneficial in preclinical studies by reducing drug testing costs and minimizing the excessive use of animal models. This is especially significant in immuno-oncology research, where selecting an appropriate in vivo model poses challenges due to differences in protein structures across species and decisions regarding the use of humanized mouse models. 3DCC has the potential to represent fully human research models hence avoiding the complications of GvHD (graft versus host disease). In our study, we presented a potency of 3D co-culture of cancer RL95-2 endometrium cells and PBMCs and we indicated their use in further stages of immune-therapeutics testing. We also confirmed the phenomena that the 3D structures grow on top of the hydrogel making them accessible to both small molecules as well as large molecules like: antibodies, Antibody-Drug-Conjugates (ADCs), cytokines, CAR-T therapy, oncolytic viruses, that consists key technical advantage of our technics. We used protein-based hydrogel LifeGel® for creating 3D cell co-culture of cancer and immune cells. We demonstrated the new in vitro model on which the potency of immune checkpoint inhibitors, was verified. In our assay we verified the potential of therapeutic antibodies used in the clinic: atezolizumab (anti PD-L1) and onvatilimab (anti-VISTA), and also newly-developed bi-speccifics antibodies. After the co-culture with PBMCs in the presence of tested immunotherapeutics, the viability of cancer cells was evaluated using colorimetric assay. The morphological parameters of tumor spheroids after co-culture with immune cells were assessed using AnaSP software. It should be underlined that our 3DCC study showed more clinically predictive testing results when comparing to other pre-clinical models. Furthermore, we confirmed that not only immortalized cancer cells but also 3D structures of patient-derived tumoroids or patient-derived xenograft models may be used in co-culture with immune cells for drug screening and immuno-testing purposes. We also confirmed the phenomena that the 3D structures grow on top of the hydrogel making them accessible to both small molecules as well as large molecules like: antibodies, Antibody-Drug-Conjugates (ADCs), cytokines, CAR-T therapy, oncolytic viruses, etc. In the realm of cancer research, 3D cell cultures showcase a predictive power in assessing the mechanistic effects and anticancer effects of drugs that rivals traditional in vivo research models. LifeGels® biophysical parameters can be modified: hardness, density and elasticity, creating an environment adapted to every characteristic of cancer cells, making them accessible to immune cells evasion. The unique property of our approach is to use 3DCC in immune-oncology research as high-throughput screening (HTS), high-content analysis and fully-automated processing. Citation Format: Justyna Kocik-Krol, David Earnshaw, Marcin Krzykawski. The highly predictive 3D Cell Co-Culture Model for Immunotherapy studies [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy; 2024 Oct 18-21; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2024;12(10 Suppl) nr A020.

Engineering Biomaterials to Model Immune‐Tumour Interactions In Vitro

Synthetic Matrix Scaffolds Engineer the In Vivo Tumor Immune Microenvironment for Immunotherapy Screening

Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies

Engineering of biomaterials for tumor modeling

3D cancer models: One step closer to in vitro human studies

Modelling the tumor immune microenvironment for precision immunotherapy

Bioengineered tissue models for the development of dynamic immuno-associated tumor models and high-throughput immunotherapy cytotoxicity assays

Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening

Regenerative Medicine and Immunotherapies

Abstract A020: The highly predictive 3D Cell Co-Culture Model for Immunotherapy studies

Construction of 3D Tumor in Vitro Models with an Immune Microenvironment Exhibiting Similar Tumor Properties and Biomimetic Physiological Functionality.

Bioengineered 3D Scaffolds in Cancer Research: Focus on Epithelial to Mesenchymal Transition and Drug Screening

High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment

Biomaterials' enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment

Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies

Multiple Comparisons of Three Different Sources of Biomaterials in the Application of Tumor Tissue Engineering in Vitro and in Vivo.

Biomaterials tools to modulate the tumour microenvironment in immunotherapy

Tumor-Infiltration Mimicking Model of Contaminated Ovarian Tissue as an Innovative Platform for Advanced Cancer Research

Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells

Emerging biomaterials for tumor immunotherapy

Biomacromolecular hydrogel scaffolds from microfluidics for cancer therapy: A review